Vasohibin: the feedback on a new inhibitor of angiogenesis

Por Kerbel, Robert S.
Publicado em 2004

Improving Conventional or Low Dose Metronomic Chemotherapy with Targeted Antiangiogenic Drugs

Por Kerbel, Robert S.
Publicado em 2007

Reappraising antiangiogenic therapy for breast cancer

Por Kerbel, Robert S.
Publicado no Breast (2011)

Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer

Por Kerbel, Robert S.
Publicado no Breast (2009)

Tumor Angiogenesis

Por Kerbel, Robert S.
Publicado no N Engl J Med (2008)

Exploiting drug repositioning and the brain microenvironment to treat brain metastases

Por Kerbel, Robert S.
Publicado no Neuro Oncol (2016)

Therapy-activated stromal cells can dictate tumor fate

Por Kerbel, Robert S., Shaked, Yuval
Publicado no J Exp Med (2016)

Preclinical approaches to study the biology and treatment of brain metastases

Por Cruz-Muñoz, William, Kerbel, Robert S.
Publicado no Semin Cancer Biol (2010)

Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma

Por Kuczynski, Elizabeth A., Kerbel, Robert S.
Publicado no Chin J Cancer (2016)

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis

Por Ebos, John M. L., Kerbel, Robert S.
Publicado no Nat Rev Clin Oncol (2011)

Effective Treatment of Advanced Human Melanoma Metastasis in Immunodeficient Mice Using Combination Metronomic Chemotherapy Regimens

Por Cruz-Munoz, William, Man, Shan, Kerbel, Robert S.
Publicado em 2009

Metronomic chemotherapy for triple negative breast cancer?

Por Di Desidero, Teresa, Kerbel, Robert S., Bocci, Guido
Publicado no Aging (Albany NY) (2016)

A MODEL OF POSTSURGICAL ADVANCED METASTATIC BREAST CANCER MORE ACCURATELY REPLICATES THE CLINICAL EFFICACY OF ANTIANGIOGENIC DRUGS

Por Guerin, Eric, Man, Shan, Xu, Ping, Kerbel, Robert S.
Publicado no Cancer Res (2013)

Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy

Por Ebos, John M.L., Lee, Christina R., Kerbel, Robert S.
Publicado em 2009

Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note

Por Paez-Ribes, Marta, Man, Shan, Xu, Ping, Kerbel, Robert S.
Publicado no PLoS One (2016)

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

Por Bocci, Guido, Francia, Giulio, Man, Shan, Lawler, Jack, Kerbel, Robert S.
Publicado em 2003

Gene Expression Analysis of Tumor Spheroids Reveals a Role for Suppressed DNA Mismatch Repair in Multicellular Resistance to Alkylating Agents

Por Francia, Giulio, Man, Shan, Teicher, Beverly, Grasso, Luigi, Kerbel, Robert S.
Publicado em 2004

Drug rechallenge and treatment beyond progression—implications for drug resistance

Por Kuczynski, Elizabeth A., Sargent, Daniel J., Grothey, Axel, Kerbel, Robert S.
Publicado no Nat Rev Clin Oncol (2013)

Early treatment of HER2-amplified brain tumors with targeted NK-92 cells and focused ultrasound improves survival

Por Alkins, Ryan, Burgess, Alison, Kerbel, Robert, Wels, Winfried S., Hynynen, Kullervo
Publicado no Neuro Oncol (2016)

Mouse models of advanced spontaneous metastasis for experimental therapeutics

Por Francia, Giulio, Cruz-Munoz, William, Man, Shan, Xu, Ping, Kerbel, Robert S.
Publicado no Nat Rev Cancer (2011)